Document is current
Any future updates will be listed below
-
Authors
Felnhofer, Anna https://orcid.org/0000-0002-0081-7489
Goreis, Andreas https://orcid.org/0000-0001-8994-964X
Weiss, Lisa
Haslacher, Helmuth https://orcid.org/0000-0003-4605-2503
Nigmann, Charlotte https://orcid.org/0000-0002-3692-8754
Skacel, Gabriele
Marculescu, Rodrig https://orcid.org/0000-0003-1772-6695
Plener, Paul L. https://orcid.org/0000-0003-4333-1494
Greber-Platzer, Susanne https://orcid.org/0000-0002-3706-8370
Kothgassner, Oswald D.
- License Information
-
More Information
Article History
Received: 24 October 2024
Revised: 28 May 2025
Accepted: 11 June 2025
First Online: 24 September 2025
Competing interests
: The authors declare that they have no conflict of interest with regards to this study. In addition, PLP declares that he is an advisor for Boehringer-Ingelheim and received speaker honoraria from GLK, Janssen, InfectoPharm and Oral B.
: All procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the ethics committee of the Medical University of Vienna (vote no. 2170/2019).
: Written informed consent was obtained from all participants.
